136 related articles for article (PubMed ID: 31852310)
1. CYLD expression in dendritic cells involved in the immunoregulation of pulmonary adenocarcinoma via NF-κB pathway.
Yu Q; Lei Y; Huang Y; Zhang J; Chen Y; Chen K; Lin J; Sun S; Lin X
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):137-142. PubMed ID: 31852310
[TBL] [Abstract][Full Text] [Related]
2. IL-33 drives the antitumour effects of dendritic cells via upregulating CYLD expression in pulmonary adenocarcinoma.
Zhang J; Chen Y; Chen K; Huang Y; Xu X; Chen Q; Huang C; Luo J; Lin X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1335-1341. PubMed ID: 30964341
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.
Srokowski CC; Masri J; Hövelmeyer N; Krembel AK; Tertilt C; Strand D; Mahnke K; Massoumi R; Waisman A; Schild H
Blood; 2009 Jun; 113(23):5891-5. PubMed ID: 19342479
[TBL] [Abstract][Full Text] [Related]
4. miR-181d regulates human dendritic cell maturation through NF-κB pathway.
Su XW; Lu G; Leung CK; Liu Q; Li Y; Tsang KS; Zhao SD; Chan DTM; Kung HF; Poon WS
Cell Prolif; 2017 Oct; 50(5):. PubMed ID: 28731516
[TBL] [Abstract][Full Text] [Related]
5. miR-130b regulates B cell proliferation via CYLD-mediated NF-κB signaling.
Wu M; Zhao J; Wu W; Hao C; Yang Y; Zhang J
Exp Cell Res; 2024 Jan; 434(1):113870. PubMed ID: 38049082
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
7. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
8. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
[TBL] [Abstract][Full Text] [Related]
9. Mutated cylindromatosis gene affects the functional state of dendritic cells.
Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
11. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Minderman M; Lantermans HC; Grüneberg LJ; Cillessen SAGM; Bende RJ; van Noesel CJM; Kersten MJ; Pals ST; Spaargaren M
Blood Cancer J; 2023 Mar; 13(1):37. PubMed ID: 36922488
[TBL] [Abstract][Full Text] [Related]
12. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
13. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
14. KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-κB signaling.
Yuan H; Wei S; Ren Z; Li F; Liu B; Liu R; Zhang X
Int Immunopharmacol; 2023 Jan; 114():109202. PubMed ID: 36538852
[TBL] [Abstract][Full Text] [Related]
15. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
Tsagaratou A; Grammenoudi S; Mosialos G
Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
[TBL] [Abstract][Full Text] [Related]
16. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.
Alameda JP; García-García VA; López S; Hernando A; Page A; Navarro M; Moreno-Maldonado R; Paramio JM; Ramírez Á; García-Fernández RA; Casanova ML
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201751
[TBL] [Abstract][Full Text] [Related]
17. Per a 10 protease activity modulates CD40 expression on dendritic cell surface by nuclear factor-kappaB pathway.
Goel C; Kalra N; Dwarakanath BS; Gaur SN; Arora N
Clin Exp Immunol; 2015 May; 180(2):341-51. PubMed ID: 25492061
[TBL] [Abstract][Full Text] [Related]
18. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
[TBL] [Abstract][Full Text] [Related]
19. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression.
Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z
Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066
[TBL] [Abstract][Full Text] [Related]
20. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium.
Byun JY; Yune TY; Lee JY; Yeo SG; Park MS
Mediators Inflamm; 2010; 2010():796315. PubMed ID: 20414373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]